Epidemiology of Diabetes Mellitus in China

The Epidemiology of Diabetes Mellitus: Second Edition

Volumn , Issue , 2008, Pages 179-206

  Chan, Juliana C N ^a   Cockram, Clive S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Childhood obesity and diabetes; China diabetes mellitus epidemiology; Chinese Da Qing Diabetes Prevention Program; Diabetes phenotypic heterogeneity; Diabetes socioeconomic impact; Diabetic kidney disease; Gestational diabetes mellitus; High sensitivity C reactive protein (hsCRP) and interleukin presence; Hyperglycemia and type 2 diabetes

Indexed keywords

EID: 75149182907     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470779750.ch15     Document Type: Chapter

References (223)

1. World Health Organization (2006) Preventing Chronic Diseases: A Vital Investment. http://www.who.int/chp/chronic_disease_report/en/index.html (last accessed 1 June 2006).
2. Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature, 414, 782-787.
3. Yoon, K.H. Lee, J.H., Kim, J.W., et al. (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet, 368, 1681-1688.
4. Roglic, G., Unwin, N., Bennett, P. et al. (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care, 28, 2130-5.
5. International Diabetes Federation (2006) Facts and figures. Cost of diabetes, http://www.idf.org/home/ (last accessed on 1 June 2006).
6. Lin, T., Chou, P., Lai, M. et al. (2001) Direct cost-of-illness of patients with diabetes mellitus in Taiwan. Diabetes Research and Clinical Practice, 54 (Suppl 1), 43-6.
7. Chen, X., Tang, L. and Chen, H. (2003) Assessing the impact of complications on the costs of type 2 diabetes in urban China. Chinese Journal of Diabetes, 11, 238-41.
8. Wong, K.C. and Wang, Z. (2006) Prevalence of type 2 diabetes mellitus of Chinese populations in mainland China, Hong Kong, and Taiwan. Diabetes Research and Clinical Practice, 73 (2), 126-34.
9. Cutter, J., Tan, B. and Chew, S. (2001) Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bulletin of the World Health Organization, 79, 908-15.
10. Soderberg, S., Zimmet, P., Tuomilehto, J. et al. (2005) Increasing prevalence of type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabetic Medicine: A Journal of the British Diabetic Association, 22, 61-8.
11. Wild, S., Roglic, G., Green, A. et al. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-53.
12. Gu, D., Reynolds, K., Duan, X., et al. (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia, 46, 1190-8.
13. Sayegh, H.A. and Jarrett, R.J. (1979) Oral glucose tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey. Lancet, II, 432-3.
14. World Health Organization, Department of Non-communicable Disease Surveillance (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. WHO, Geneva.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26, 3160-7.
16. Cockram, C.S., Lau, J.T.F., Chan, A.Y.W. et al. (1992) Assessment of glucose tolerance test criteria for diagnosis of diabetes in Chinese subjects. Diabetes Care, 15, 988-90.
17. Nakagami, T., Qiao, Q., Tuomilehto, J., et al. DECODA Study Group, Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia; International Diabetes Epidemiology Group (2002) The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. Diabetes Research and Clinical Practice, 55, 35-43.
18. Nakagami, T. (2004) Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia, 47, 385-94.
19. Hu, Y.H., Pan, X.R., Liu, P.A. et al. (1991) Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: the Da Qing IGT and Diabetes Study. Acta Diabetologica, 28, 169-73.
20. Jia, W.P., Pang, C., Chen, L., et al. (2007) Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia, 50, 286-292.
21. Cheung, B.M., Wat, N.M., Man, Y.B., et al. (2007) Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care, 30, 1430-1436.
22. Tso, A.W., Xu, A., Sham, P.C. et al. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care, 30, 2667-2672.
23. Ma, S., Cutter, J., Tan, C. et al. (2003) Associations of diabetes mellitus and ethnicity with mortality in a multiethnic Asian population: data from the 1992 Singapore National Health Survey. American Journal of Epidemiology, 158, 543-52.
24. Yang, X., Zhang, H., Dong, L. et al. (2004) The effect of glucose levels on fetal birth weight: a study of Chinese gravidas in Tianjin, China. The Journal of Diabetic Complications, 18, 37-41.
25. Yang, X., Hsu-Hage, B., Zhang, H. et al. (2003) Gestational diabetes mellitus in women of single gravidity in Tianjin City, China. Diabetes Care, 25, 847-51.
26. Ko, G.T.C., Tam, W.H., Chan, J.C.N. and Rogers, M. (2002) Prevalence of gestational diabetes mellitus in Hong Kong based on the 1998 WHO criteria. Diabetic Medicine: A Journal of the British Diabetic Association, 19, 180.
27. Ko, G.T.C., Chan, J.C.N., Tsang, L.W.W. et al. (1999) Glucose intolerance and other cardiovascular risk factors in Chinese women with a history of gestational diabetes mellitus. Australian and New Zealand Journal of Obstetrics and Gynaecology, 39, 478-83.
28. Ko, G.T.C., Chan, J.C.N., Tsang, L.W.W. et al. (2000) Outcomes of screening for glucose intolerance in high risk Hong Kong Chinese. Diabetes Care, 23, 1290-4.
29. Alberti, G., Zimmet, P., Shaw, J., et al. (2004) Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation consensus workshop. Diabetes Care, 27, 1798-811.
30. Kitagawa, T., Owada, M., Urakami, T. and Yamauchi, K. (1998) Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat. Clinical Pediatrics, 37, 111-15.
31. Sung, R.Y., Tong, P.C.Y., Yu, C.W. et al. (2002) High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9-12 years. Diabetes Care, 26, 250-1.
32. Wei, J., Sung, F., Lin, C. et al. (2003) National surveillance for type 2 diabetes mellitus in Taiwanese children. The Journal of the American Medical Association, 290, 1345-50.
33. Urakami, T., Kubota, S., Nitadori, Y. et al. (2005) Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care, 28, 1876-81.
34. Wei, J., Sung, F., Li, C. et al. (2003) Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care, 26, 343-8.
35. Woo, K.S., Chook, P., Yu, C.W. et al. (2004) Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation, 109, 1981-6.
36. Cook, S., Weitzman, M., Auinger, P. et al. (2003) Prevalence of a metabolic syndrome phenotype in adolescents. Archives of Pediatrics and Adolescent Medicine, 157, 821-7.
37. Ozaki, R. Qiao, Q., Wong, G.W. et al. (2007) Overweight, family history of diabetes and attending schools of lower academic grading are independent predictors for metabolic syndrome in Hong Kong Chinese adolescents. Arch Dis Child, 92, 224-228.
38. Wang, Y., Ge, K. and Popkin, B. (2000) Tracking of body mass index from childhood to adolescence: a 6-years follow-up study in China. The American Journal of Clinical Nutrition, 72, 1018-24.
39. Li, X., Li, T., Yang, Z. et al. (2000) A nine-year prospective study on the incidence of childhood type 1 diabetes mellitus in China. Biomedical and Environmental Sciences, 13, 263-7.
40. Huen, K.F., Low, L.C., Wong, G.W. et al. (2000) Epidemiology of diabetes mellitus in children in Hong Kong: the Hong Kong childhood diabetes register. Journal of Pediatrics Endocrinology and Metabolism, 13, 297-302.
41. Pociot, F. and McDermott, M. (2002) Genetics of type 1 diabetes. Genes and Immunity, 3, 235-49.
42. Penny, M.A., Jenkins, D., Mijovic, C. et al. (1992) Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes, 41, 914-30.
43. Chuang, L., Jou, T., Hu, C. et al. (1994) HLA-DQB1 codon 57 and IDDM in Chinese living in Taiwan. Diabetes Care, 17, 863-8.
44. Chuang, L., Jou, T., Wu, H. et al. (1995) HLA-DQA1 genotypes and its interaction with HLA-DQB1 in Chinese IDDM living in Taiwan. Proceedings of the National Science Council, Republic of China. Part B, Life Sciences, 19, 73-9.
45. Kelly, M.A., Chan, J.C.N., Heward, J. et al. (2000) HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population. Diabetic Medicine: A Journal of the British Diabetic Association, 18, 22-8.
46. Ueda, H., Howson, J., Esposito, L. et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility of autoimmune disesse. Nature, 423, 506-11.
47. Lee, Y., Huang, F., Lo, F. et al. (2000) Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clinical Endocrinology, 52, 153-57.
48. Ma, Y., Tang, X., Chang, W. et al. (2002) CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese. Chinese Medical Journal, 115, 1248-50.
49. Altshuler, D., Brooks, L., Chakravarti, A., et al. (2005) A haplotype map of the human genome. Nature, 437, 1299-320.
50. Ng, M.C.Y., Wang, Y., So, W.Y. et al. (2004) Ethnic differences in the linkage disequilibrium and distribution of single nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases. Genomics, 83, 559-65.
51. Eckel, R., Grundy, S. and Zimmet, P. (2005) The metabolic syndrome. Lancet, 365, 1415-28.
52. Smyth, S. and Heron, A. (2006) Diabetes and obesity: the twin epidemics. Nature Medicine, 12, 75-80.
53. Chan, J.C.N., Cheung, C.K., Swaminathan, R. et al. (1993) Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgraduate Medical Journal, 69, 204-10.
54. Cockram, C.S., Woo, J., Lau, E. et al. (1993) The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diabetes Research and Clinical Practice, 21, 67-73.
55. Yajnik, C. and Yudkin, J. (2004) The Y-Y paradox. Lancet, 363, 163.
56. He, M., Tan, K.C., Li, E.T. and Kung, A.W. (2001) Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. International Journal of Obesity and Related Metabolic Disorders, 25, 748-52.
57. Ko, G.T.C., Chan, J.C.N., Woo, J. and Cockram, C.S. (1999) Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. International Journal of Obesity, 23, 1136-42.
58. Huxley, R., James, W.P., Barzi, F. et al. (2008) Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev, 9 (Suppl 1), 53-61.
59. WHO Expert Consultation (2004) Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363, 157-63.
60. Schooling, C.M., Lam, T.H., Li, Z.B. et al. (2006) Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Archives of Internal Medicine, 166, 1498-1504.
61. Thomas, G.N., Schooling, C.M., McGhee, S.M. et al. (2007) Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf), 66, 666-671.
62. Jia, W.P., Lu, J.X., Kiang, K.S. et al. (2003) Prediction of abdominal visceral obesity from body mass index, waist circumference and waist-hip ratio in Chinese adults: receiver operating characteristics curves analysis. Biomedical and Environ-mental Sciences, 2003, 206-11.
63. Jia, W., Xiang, K., Chen, L. et al. (2002) Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obesity Reviews, 3, 157-65.
64. Liu, K., Chan, Y., Chan, W. et al. (2003) Sonographic measurement of mesenteric fat thickness and its association with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. International Journal of Obesity, 27, 1267-73.
65. Liu, K., Chan, Y.L., Chan, J.C. et al. (2006) Mesenteric fat thickness as an independent determinant of fatty liver. International Journal of Obesity, 30, 787-93.
66. Liu, K.H., Chan, Y.L., Chan, J.C.N. and Chan, W.B. (2005) Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Atherosclerosis, 179, 299-304.
67. Liu, K., Chan, Y., Chan, W. et al. (2006) Mesenteric fat thickness is an independent determinant of metabolic syndrome and defines subjects with increased carotid intima-media thickness. Diabetes Care, 29, 379-84.
68. Despres, J.P., Lemieux, I., (2000) Abdominal obesity and metabolic syndrome. Nature, 444, 881-887.
69. Alberti, K., Zimmet, P. and Shaw J. (2005) The metabolic syndrome-a new worldwide definition. Lancet, 366, 1059-62.
70. Tan, C.E., Ma, S., Wai, D. et al. (2004) Can we apply the National Cholesterol Education Program Adult Treatment Panel Definition of the metabolic syndrome to Asians? Diabetes Care, 27, 1182-6.
71. Gu, D., Reynolds, K., Wu X., et al. (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet, 365, 1398-405.
72. Chan, J.C.N., Tong, P.C.Y. and Critchley, J.A.J.H. (2002) The insulin resistance syndrome-mechanism of clustering of cardiovascular risk. Seminars in Vascular Medicine, 2, 45-57.
73. Alberti, K.G., Zimmet, P. and Shaw J. (2007) International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med, 24, 451-463.
74. Gillies, C.L., Abrams, K.R., Lambert P.C., et al. (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Bmj, 334, 299
75. Chan, J.C.N., Cheung, J.C.K., Lau, E.M.C. et al. (1996) The metabolic syndrome in Hong Kong Chinese-the inter-relationships amongst its components analysedby structural equation modelling. Diabetes Care, 19, 953-9.
76. Sawada, S., Lee, I., Muto, T. et al. (2003) Cardiorespiratory fitness and the incidence of type 2 diabetes: prospective study of Japanese men. Diabetes Care, 26, 2918-22.
77. Nakanishi, N. Takatorige, T. and Suzuki K. (2005) Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Industrial Health, 43, 295-301.
78. Ko, G.T.C., Chan, J.C.N., Tsang, L.W. et al. (2000) Smoking and diabetes in Chinese men. Postgraduate Medical Journal, 77, 240-3.
79. Hancox, R., Milne, B. and Poulton, R. (2004) Association between child and adolescent television viewing and adult health: a longitudinal birth cohort study. Lancet, 364, 257-62.
80. Pereira, M., Kartashov, A., Ebbeling, C. et al. (2005) Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet, 365, 36-42.
81. Glumer, C., Carstensen, B., Sandbaek, A. et al. (2004) A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care, 27, 727-33.
82. Meigs, J., Williams, K., Sullivan, L. et al. (2004) Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care, 27, 1417-26.
83. Stern, M., Williams, K. and Haffner, S. (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Annals of Internal Medicine, 136, 575-81.
84. Aekplakorn, W., Bunnag, P., Woodward, M., et al. (2006) A risk score for predicting incident diabetes in the Thai population. Diabetes Care, 29, 1872-1877.
85. Maty, S., Everson-Rose, S., Hann, M. et al. (2005) Education, income, occupation, and the 34-year incidence (1965-99) of type 2 diabetes in the Alameda County Study. International Journal of Epidemiology, 34, 1274-81.
86. Connolly, V., Unwin, N., Sherriff, P. et al. (2000) Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. Journal of Epidemiology and Community Health, 54, 173-7.
87. Kumari, M., Head, J. and Marmot, M. (2004) Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II Study. Archives of Internal Medicine, 164, 1873-80.
88. Pan, X.R., Yang, W.Y., Li, G.W. and Liu, J. (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care, 20, 1664-9.
89. Ko, G.T.C., Chan, J.C.N. and Cockram, C.S. (2001) A low socioeconomic class is associated with diabetes and metabolic syndrome in Hong Kong Chinese. European Journal of Epidemiology, 17, 289-95.
90. Hales, C.N. and Barker, D.J.P. (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia, 35, 595-601.
91. Mi, J., Law, C., Zhang, K.L. et al. (2000) Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Annals of Internal Medicine, 132, 253-60.
92. Cheung, N. and Byth, K. (2003) Population health significance of gestational diabetes. Diabetes Care, 26, 2005-9.
93. Yue, D., Molyneaux, L., Ross, G. et al. (1996) Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabetic Medicine: A Journal of the British Diabetic Association, 13, 748-52.
94. Lao, T.T., Tse, K.Y., Chan, L.Y. et al. (2003) HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care, 26, 3011-16.
95. Lao, T.T. and Ho, L.F. (2001) Alpha-thalassaemia trait and gestational diabetes mellitus in Hong Kong. Diabetologia, 44, 966-71.
96. Lao, T.T., Chan, P.L. and Tam, K.F. (2001) Gestational diabetes mellitus in the last trimester-a feature of maternal iron excess? Diabetic Medicine: A Journal of the British Diabetic Association, 18, 218-23.
97. Tong, P.C.Y., Ng, M.C.Y., Ho, C.S. et al. (2001) Thalassemia minor is associated with insulin resistance in high-risk subjects for diabetes. Diabetes, 50 (Suppl 2), A103.
98. Fernandez-Real, J-M., Ricart-Engel, W., Arroyo, E. et al. (1998) Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care, 21, 62-68.
99. Ferrannini, E. (2000) Insulin resistance, iron, and the liver. Lancet, 355, 2181-2.
100. Pradhan, A.D., Manson, J.E., Rifai, N. et al. (2001) C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. The Journal of the American Medical Association, 286, 327-34.
101. Mendall, M.A. (1998) Inflammatory responses and coronary heart disease: the dirty chicken hypothesis of cardiovascular risk factors. British Medical Journal, 316, 953-4.
102. Tong, P.C.Y., Ho, C.S., Yeung, V.T.F. et al. (2005) Low testosterone and insulin-like growth factor-I but high C-reactive protein are independent predictors for metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 90, 6418-23.
103. Tan, K.C., Wat, N.M., Tam, S.C. et al. (2003) C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care, 26, 2323-8.
104. Tam, C.M., Leung, C.C., Noertjojo, K. et al. (2003) Tuberculosis in Hong Kong-patient characteristics and treatment outcome. Hong Kong Medical Journal, 9, 83-90.
105. Cheng, A.Y.S., Kong, A.P.S., Wong, V.W.S. et al. Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. (2006) Diabetologia, 49 (8), 1777-84.
106. Chen, L., Hwang, S., Tsai, S. et al. (2000) Glucose intolerance in Chinese patients with chronic hepatitis C. World Journal of Gastroenterology, 9, 505-8.
107. Ko, G.T.C., Chan, J.C.N., Yeung, V.T.F. et al. (1998) Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients. Annals of Clinical Biochemistry, 35, 761-7.
108. Thai, A.C., Ng, W.Y., Loke, K.Y. et al. (1997) Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Dia-betologia, 40, 1425-30.
109. Pan, C.Y., So, W.Y., Khalid, B.A. et al. (2004) Metabolic, immunological and clinical characteristics in newly diagnosed Asian diabetes patients aged 12-40 years. Diabetic Medicine: A Journal of the British Diabetic Association, 21, 1007-13.
110. Ng, M.C.Y., Lee, S.C., Ko, G.T.C. et al. (2001) Familial early onset type 2 diabetes in Chinese: the more significant roles of obesity and genetics than autoimmunity. Diabetes Care, 24, 667-71.
111. Turner, R.C., Stratton, I., Horton, V. et al. (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet, 350, 1288-93.
112. Yang, L., Zhou, Z.G., Huang, G. et al. (2005) Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetes. World Journal of Gastroenterology, 11, 2900-5.
113. Banerji, M.A., Chaiken, R.L., Huey, H. et al. (1994) GAD antibody negative NIDDM in adult Black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush Diabetes. Diabetes, 43, 741-5.
114. Tan, K.C.B., Mackay, I.R., Zimmet, P.Z. et al. (2000) Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care, 23, 335-8.
115. Li, J.K.Y., Chan, J.C.N., Zimmet, P.Z. et al. (2000) Young Chinese adults with new onset of diabetic ketoacidosis-clinical course, autoimmune status and progression of pancreatic beta cell function. Diabetic Medicine: A Journal of the British Diabetic Association, 17, 295-8.
116. Chan, J.C.N. and Ng, M.C.Y. (2003) Lessons learned from young onset diabetes in China. Current Diabetes Reports, 3, 101-7.
117. Xu, J.Y., Dan, Q.H., Chan, V. et al. (2005) Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. European Journal of Human Genetics, 13, 422-7.
118. Xu, J.Y., Chan, V., Zhang, W.Y. et al. (2002) Mutations in the hepatocyte nuclear factor-1alpha gene in Chinese MODY families: prevalence and functional analysis. Diabetologia, 45, 744-6.
119. Yoon, K., Ko, S., Cho, J. et al. (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. The Journal of Clinical Endocrinology and Metabolism, 88, 2300-8.
120. Boyko, E., Leonetti, D., RW, B. and Fujimoto, W. (1997) Fasting insulin level underestimates risk of non-insulin-dependent diabetes mellitus due to confounding by insulin secretion. American Journal of Epidemiology, 145, 18-23.
121. Chan, W.B., Tong, P.C.Y., Chow, C.C. et al. (2004) The associations of body mass index, C peptide and metabolic status in Chinese type 2 diabetic patients. Diabetic Medicine: A Journal of the British Diabetic Association, 21, 349-53.
122. Ng, M.C.Y., Li, J.K.Y., So, W.Y. et al. (2000) Nature or nurture-an insightful illustration from a Chinese family with hepatocyte nuclear factor 1-alpha diabetes (MODY3). Diabetologia, 43, 816-18.
123. Chan, J.C.N., Hawkin, B.R. and Cockram, C.S. (1990) A Chinese family with non-insulin-dependent diabetes of early onset. Diabetic Medicine: A Journal of the British Diabetic Association, 7, 211-14.
124. Yokoyama, H., Okudaira, M., Otani, T. et al. (1998) High incidence of diabetic nephropathy in early onset Japanese NIDDM patients. Risk analysis. Diabetes Care, 21, 1080-5.
125. Ko, G.T.C., Chan, J.C.N., Lau, M.S.W. and Cockram, C.S. (2000) Diabetic microangiopathic complications in young Chinese diabetic patients-a clinic-based cross-sectional study. Journal of Diabetes and its Complications, 13, 300-6.
126. Chan, J.C.N., Wat, N.M.S., So, W.Y. et al. (2004) RAAS blockade and renal disease in type 2 diabetic patients: an Asian perspective from the RENAAL Study. Diabetes Care, 27, 874-9.
127. So, W.Y., Chan, N., Tong, P.C.Y. et al. (2004) Effect of RAAS inhibition on survival and renal outcomes in 3737 Chinese type 2 diabetic patients. Hypertension, 44, 294-9.
128. Fajans, S.S., Bell, G.I. and Polonsky, K.S. (2001) Molecular mechanisms and clinical pathophysiology of maturity onset diabetes of the young. The New England Journal of Medicine, 345, 971-80.
129. Hattersley, A. and Pearson, E. (2006) Minireview: Pharmacogenetics and beyond: the interaction of therapeutic response, β-cell physiology and genetics in diabetes. Endocrinology, 147 (6), 2657-63.
130. Ng, M.C.Y., Yeung, V.T.F., Chow, C.C. et al. (2000) Mitochondrial DNA A3243G mutation in patients with early or late onset type 2 diabetes mellitus in Hong Kong Chinese. The Journal of Endocrinology, 52, 557-64.
131. Ji, L., Hou, X. and Han, X. (2001) Prevalence and clinical characteristics of mitochondrial tRNA leu(UUR) mt 3243 A→G and ND-1 gene mt 3316 G→A mutations in Chinese patients with type 2 diabetes. Diabetes Research and Clinical Practice, 114, 1205-7.
132. Xiang, K., Wang, Y., Wu, S. et al. (1997) Mitochondrial tRNA(Leu(UUR)) gene mutation diabetes mellitus in Chinese. Chinese Medical Journal, 110, 372-8.
133. Park, K.S., Chan, J.C., Chuang, L.M. et al. (2008) A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia, 51, 602-608.
134. Chinnery, P.F., Elliott, H.R., Patel, S. et al. (2005) Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. Lancet, 366, 1650-1.
135. Zhao, H.L., Lai, F.M.M., Tong, P.C.Y. et al. (2003) Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes, 52, 2759-66.
136. Clark, A. and Nilsson, M.R. (2004) Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes? Diabetologia, 47, 157-69.
137. Clark, A., Wells, C.A., Buley, I.D. et al. (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Research (Edinburgh, Lothian), 9, 151-9.
138. Hayden, M.R., Tyagi, S.C., Kerklo, M.M. and Nicolls, M.R. (2005) Type 2 diabetes mellitus as a conformational disease. Journal of Pancreas, 6, 287-302.
139. Poa, N., Cooper, G. and Edgar, P. (2003) Amylin gene promoter mutations predispose to type 2 diabetes in New Zealand Maori. Diabetologia, 46, 574-8.
140. Lee, S.C., Hashim, Y., Li, J.K.Y. et al. (2001) The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels. The Journal of Endocrinology, 54, 541-6.
141. Seino S. (2001) S20G mutation of the amylingene is associated with type II diabetes in Japanese. Study Group of Comprehensive Analysis of Genetic Factors in Diabetes Mellitus. Diabetologia, 44, 906-9.
142. Ma, Z., Westermark, G.T., Sakagashira, S. et al. (2001) Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid, 8, 242-9.
143. Anderson, P.J., Critchley, J.A.J.H., Chan, J.C.N. et al. (2001) Factor analysis of the metabolic syndrome: obesity versus insulin resistance as the central abnormality. International Journal of Obesity, 25, 1782-8.
144. Chan, J.C.N., Cheung, J.C.K., Stehouwer, C.D.A. et al. (2002) The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome-an analysis by structural equation modelling. International Journal of Obesity, 26, 994-1008.
145. Pladevall, M., Singal, B., Williams, L. et al. (2006) A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care, 29, 113-22.
146. Ang, L., Ma, S., Cutter, J. et al. (2005) The metabolic syndrome in Chinese, Malays and Asian Indians. Factor analysis of data from the 1998 Singapore National Health Survey. Diabetes Research and Clinical Practice, 67, 53-62.
147. Wang, J., Qiao, Q., Miettinen, M. et al. (2004) The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care, 27, 2429-37.
148. Li, J.K.Y., Ng, M.C.Y., So, W.Y. et al. (2006) Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews, 22, 46-52.
149. Ng, M.C., So, W.Y., Cox, N.J. et al. (2004) Genome wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-25. Diabetes, 53, 2676-83.
150. Xiang, K., Wang, Y., Zheng, T. et al. (2004) Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes, 53, 228-34.
151. Zhao, J., Xiong, M., Huang, W. et al. (2005) An autosomal genomic scan for loci linked to type 2 diabetes in northern Han Chinese. Journal of Molecular Medicine, 83, 209-15.
152. Ng, M.C.Y., So, W.Y., Cox, N.J. et al. (2004) Genome wide scan for type 2 diabetes loci in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes, 53, 1609-13.
153. Chiu, Y., Chuang, L., Hsiao, C. et al. (2005) An autosomal genome-wide scan for loci linked to prediabetic phenotypes in nondiabetic Chinese subjects from the Stanford Asia-Pacific Program of Hypertension and Insulin Resistance Family Study. Diabetes, 54, 1200-6.
154. Luo, T., Zhao, Y., Li, G. et al. (2001) A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia, 44, 501-6.
155. Ng, M.C., Park, K.S., Oh, B. et al. (2008) Implication of Genetic Variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2 and FTO in Type 2 Diabetes and Obesity in 6719 Asians. Diabetes.
156. Vague J. (1991) Regulation of the Fat Mass. Obesities, John Libbey & Co. Ltd./Edition Solal, Marseille, France, pp. 25-34.
157. Björntorp, P. (1991) Metabolic implications of body fat distribution. Diabetes Care, 14, 1132-43.
158. Lee, Z.S.K., Critchley, J.A.J.H., Tomlinson, B. et al. (2001) Urinary epinephrine and norepinephrine with obesity, insulin and the metabolic syndrome in Hong Kong Chinese. Metabolism: Clinical and Experimental, 50, 135-43.
159. Lee, Z.S.K., Chan, J.C.N., Yeung, V.T.F. et al. (1999) Plasma insulin, growth hormone, cortisol and central obesity among young Chinese type 2 diabetic patients. Diabetes Care, 22, 1450-7.
160. Yang, W. and Chuang, L. (2006) Human genetics of adiponectin in the metabolic syndrome. Journal of Molecular Medicine, 84, 112-21.
161. Yusuf, S., Hawken, S., Ounpuu, S. et al. (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet, 366, 1640-9.
162. Lawes, C., Parag, V., Bennett, D., et al. (2004) Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care, 27, 2836-42.
163. Chi, Z., Lee, E., Lu, M. et al. (2001) Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia, 44 (Suppl 2), S82-6.
164. Wong, K.S. (1999) Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage. A prospective hospital-based study in Asia. Stroke; A Journal of Cerebral Circulation, 30, 2326-30.
165. Thomas, G.N., Lin, J.W., Lam, W.W. et al. (2003) Middle cerebral artery stenosis in type II diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the rennin-angiontensin system genes. Cerebrovascular Diseases (Basel, Switzerland), 16, 217-23.
166. Thomas, G.N., Critchley, J.A.J.H., Tomlinson, B. et al. (2003) Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabetic Medicine: A Journal of the British Diabetic Association, 20, 988-95.
167. Hu, D.Y., Pan, C.Y., Yu, J.M. et al. (2006) The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. European Heart Journal, 27, 2573-2579.
168. Sanderson, J.E., Chan, S.K., Chan, W.W. et al. (1995) The aetiology of heart failure in the Chinese population of Hong Kong-a prospective study of 730 consecutive patients. International Journal of Cardiology, 51, 29-35.
169. Chan, J.C.N. and Cockram, C.S. (1997) Diabetes mellitus in Chinese and its implications on health care. Diabetes Care, 20, 1785-90.
170. Chan, J.C.N., Ng, M.C.Y., Critchley, J.A.J.H. et al. (2001) Diabetes mellitus-a special medical challenge from a Chinese perspective. Diabetes Research and Clinical Practice, 54, S19-27.
171. Wu, A.Y., Kong, N.C., de Leon, F.A. et al. (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the Micro Albuminuria Prevalence (MAP) Study. Diabetologia, 48, 1674-5.
172. Tong, P.C., Kong, A.P., So, W.Y. et al. (2007) Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus. Diabet Med, 24, 741-746.
173. Ma, R.C., So, W.Y., Yang, X. et al. (2008) Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol, 51, 2045-2050.
174. Chan, J.C.N., Tomlinson, B., Nicholls, M.G. et al. (1996) Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with non-insulin-dependent diabetes (NIDDM). Diabetic Medicine: A Journal of the British Diabetic Association, 13, 150-5.
175. Tanaka, H., Shiohira, Y., Uezu, Y. et al. (2006) Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney International, 69, 369-74.
176. Wang, Y., Ng, M.C.Y., Lee, S.C. et al. (2003) Phenotypic heterogeneity associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care, 26, 2410-15.
177. Wang, Y., Ng, M.C.Y., So, W.Y. et al. (2005) Tumor necrosis factor alpha G-308A polymorphism increased the risk of nephropathy in obese Chinese type 2 diabetic patients. Nephrology, Dialysis, Transplantation, 20, 2733-8.
178. Tong, P.C.Y., Lee, K.F., So, W.Y. et al. (2004) Association of white blood cell counts with macrovascular and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care, 27, 216-22.
179. Chan, J.C.N., Cheung, C.K., Cheung, M.Y.F. et al. (1995) Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care, 18, 1013-14.
180. Morrish, N.J., Wang, S., Stevens, L.K. et al. (2001) Mortality and causes of death in the WHO Multinational Survey of Vascular Diseases in Diabetes. Diabetologia, 44, S14-21.
181. Karter, A., Ferrara, A., Liu, J. et al. (2002) Ethnic disparities in diabetic complications in an insured population. The Journal of the American Medical Association, 287, 2519-27.
182. Brenner, B.M., Cooper, M.E., De Zeeuw, D., et al. (2001) Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. The New England Journal of Medicine, 345, 861-9.
183. Chan, W.B., Chan, N.N., Lai, C.W.K. et al. (2006) Vascular defect beyond the endothelium in type 2 diabetic patients with overt nephropathy and moderate renal insufficiency. Kidney International, 70 (4), 711-6.
184. Kong, A.P., So, W.Y., Szeto, C.C. et al. (2006) Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney International, 69, 383-7.
185. So, W.Y., Kong, A.P., Ma, R.C., et al. (2006) Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care, 29, 2046-2052.
186. Yang, X.L., So, W.Y., Kong, A.P.S., et al. (2006) End-stage renal disease risk equations for Hong Kong Chinese type 2 diabetic patients-the Hong Kong Diabetes Registry. Diabetologia, 49 (10), 2299-308.
187. Cooper, M. (1998) Pathogenesis, prevention and treatment of diabetic nephropathy. Lancet, 352, 213-19.
188. Zhao, H.L., Tong, P.C., Lai, F.M. et al. (2005) Association of glomerulopathy with the 5'-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients. Diabetes, 53, 2984-91.
189. Liu, Y., Wat, N., Chung, S. et al. (2002) Diabetic nephropathy is associated with the 5'-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with type 2 diabetes. Diabetic Medicine: A Journal of the British Diabetic Association, 19, 113-18.
190. Wang, Y., Ng, M.C.Y., So, W.Y. et al. (2004) Prognostic effect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care, 28, 348-54.
191. Lee, Y. and Tsai, J. (2002) ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care, 25, 1002-8.
192. Wong, T.Y.H., Poon, P., Szeto, C.C. et al. (2000) Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney International, 57, 632-8.
193. Wong, T.Y., Poon, P., Chow, K.M. et al. (2003) Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney International, 63, 1831-5.
194. Baum, L., Ng, M.C.Y., So, W.Y. et al. (2005) The hepatic lipase (HL) 514C T polymorphism and its interactions with ApoC3 482C T and ApoE exon 4 polymorphisms on risk of nephropathy in Chinese type 2 diabetic patients. Diabetes Care, 28, 1704-9.
195. Ng, M.C.Y., Baum, L., So, W.Y. et al. (2006) Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and ApoC3 455T→C polymorphisms on the susceptibility of diabetic nephropathy. Clinical Genetics, 70 (1), 20-8.
196. Liu, L., Xiang, K., Zheng, T. et al. (2003) Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Molecular and Cellular Biochemistry, 254, 353-8.
197. Ng, D.P., Tai, B.C., Koh, D. et al. (2005) Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia, 48, 1008-16.
198. Crook, E., Penumalee, S., Gavini, B. and Filippova, K. (2005) Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care, 28, 2187-91.
199. Soma, J., Saito, T. and Taguma, Y. et al. (2000) High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. Journal of the American Society of Nephrology, 11, 690-9.
200. Lo, M.K.W., Lee, K.F., Chan, N. et al. (2004) Effects of gender, Helicobacter pylori (HP) and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy. Diabetes, Obesity and Metabolism, 6, 223-30.
201. Hou, F. (2006) Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand? Chinese Medical Journal, 118, 883-6.
202. Lui, S.F., Ho, Y.W., Chau, K.F. et al. (1999) Hong Kong Renal Registry 1995-1999. Hong Kong Journal of Nephrology, 1, 53-60.
203. Knowler, W.C., Barrett-Connor, E., Fowler, S.E. et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346, 393-403.
204. Lindstrom, J., Ilanne-Parikka, P., Peltonen, M. et al. (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet, 368, 1673-1679.
205. Li, G., Zhang, P., Wang, J. et al. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet, 371, 1783-1789.
206. Engelgau, M. (2005) Trying to predict the future for people with diabetes: a tough but important task. Annals of Internal Medicine, 143, 301-2.
207. Li, C., Pan, C., Lu, J. et al. (1999) Effect of metformin on patients with impaired glucose tolerance. Diabetic Medicine: A Journal of the British Diabetic Association, 16, 477-81.
208. Yang, W., Lin, L., Qi, J. et al. (2001) The preventive effect of acarbose and metformin on the progression to diabetes mellitus in the IGT population: a 3-year multicentre prospective study. Chinese Journal of Endocrinology and Metabolism, 17, 131-136.
209. Toh, C., Cutter, J. and Chew, S. (2002) School based intervention has reduced obesity in Singapore. British Medical Journal, 324, 427.
210. Sahota, P., Rudolf, M., Dixey, R. et al. (2001) Evaluation of implementation and effect of primary school based intervention to reduce risk factors for obesity. British Medical Journal, 323, 1027-29.
211. Gaede, P., Lund-Andersen, H., Parving, H.H. et al. (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med, 358, 580-591.
212. Gaede, P., Vedel, P., Larsen, N. et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England Journal of Medicine, 348, 383-93.
213. Ko, G.T.C., Li, J.K., Kan, E.C. and Lo, M.K. (2004) Effects of a structured health education program by a diabetes educator nurse on cardiovascular risk factors in Chinese type 2 diabetic patients: a 1-year prospective randomised study. Diabetic Medicine: A Journal of the British Diabetic Association, 21, 1274-9.
214. Wong, F.K., Mok, M.P., Chan, T. and Tsang, M.W. (2005) Nurse follow-up of patients with diabetes: randomized controlled trial. Journal of Advanced Nursing, 50, 391-402.
215. Leung, W.Y.S., So, W.Y., Tong, P.C.Y. et al. (2005) Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. The American Journal of Medicine, 118, 1414.e21-7.
216. So, W.Y., Tong, P.C.Y., Ko, G.T. et al. (2003) The effects of protocol driven care versus usual outpatient clinic care on survival rates in type 2 diabetic patients. The American Journal of Managed Care, 9, 606-15.
217. Wu, J.Y.F., Leung, W.Y.S., Chang, S. et al. (2006) Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. British Medical Journal, 333 (7567), 522-5.
218. Chuang, L., Tsai, S., Huang, B. and Tai T. (2002) The status of diabetes control in Asia-a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabetic Medicine: A Journal of the British Diabetic Association, 19, 978-85.
219. Bhatt, D., Steg, P., Ohman, E., et al. (2006) International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. The Journal of the American Medical Association, 11, 180-9.
220. King, H., Keuky, L., Seng, S. et al. (2005) Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet, 366, 1633-9.
221. Kosaka, K., Noda, M. and Kuzuya, T. (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Research and Clinical Practice, 67, 152-62.
222. Lo, C. (2004) The Misunderstood China. Uncovering the Truth Behind the Bamboo Curtain, Pearson/Prentice Hall, Singapore.
223. Ramachandran, A., Snehalatha, C., Mary, S., et al. (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia, 49, 289-97.